Vanderbilt-Ingran Cancer Center — Nashville, Tennessee

Vanderbilt-Ingran Cancer Center is a clinical research site located in Nashville, Tennessee, United States 37232.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Vanderbilt-Ingran Cancer Center has participated in 1 clinical trials.

Therapeutic areas: Metastatic Urothelial Cancer.

Sponsors: Matthew Galsky.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vanderbilt-Ingran Cancer Center?

Vanderbilt-Ingran Cancer Center has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vanderbilt-Ingran Cancer Center conducted?

Vanderbilt-Ingran Cancer Center has 1 clinical trials on record. Their work covers Metastatic Urothelial Cancer.

Is Vanderbilt-Ingran Cancer Center accredited by Crixeo Health?

Vanderbilt-Ingran Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Vanderbilt-Ingran Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.